Antimicrobial treatment of monomicrobial phenotypic carbapenem-resistant Klebsiella pneumoniae bacteremia: Two are better than one
Backgrounds: Infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) are emerging worldwide. The optimal treatment for CRKP infections is challenging for clinicians because therapeutic agents are greatly limited. Material and methods: A retrospective study of CRKP monomicrobial bacter...
Main Authors: | Wen-Chia Tsai, Ling-Shan Syue, Wen-Chien Ko, Ching-Lung Lo, Nan-Yao Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Journal of Microbiology, Immunology and Infection |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1684118221001882 |
Similar Items
-
Evaluation of Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae Bacteremia
by: Pınar Kıran, et al.
Published: (2020-03-01) -
Successful treatment of hypervirulent Klebsiella pneumoniae bacteremia with combination carbapenem and rifampicin
by: Yong-Chun Lin, et al.
Published: (2021-01-01) -
Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China
by: Astrid V. Cienfuegos-Gallet, et al.
Published: (2022-04-01) -
Klebsiella ESBL bacteremia-mortality and risk factors
by: Felipe Francisco Tuon, et al. -
Risk factors for KPC-producing Klebsiella pneumoniae bacteremia
by: Felipe F. Tuon, et al.